Knygos.lt nariams
Knygos.lt nariams
- Išsiųsime per 12–18 d.d.
/images/books/13376492/9783838201351.jpg)
- Autorius: Vanessa Platé
- Leidėjas: Ibidem Press
- Metai: 2010
- Puslapiai: 174
- ISBN-10: 3838201353
- ISBN-13: 9783838201351
- Formatas: 14.8 x 21 x 1 cm, minkšti viršeliai
- Kalba: Anglų
The Impact of Off-Label, Compassionate, and Unlicensed Use on Health Care Laws in Preselected Countries (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Aprašymas
In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use--generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.
- Autorius: Vanessa Platé
- Leidėjas: Ibidem Press
- Metai: 2010
- Puslapiai: 174
- ISBN-10: 3838201353
- ISBN-13: 9783838201351
- Formatas: 14.8 x 21 x 1 cm, minkšti viršeliai
- Kalba: Anglų
In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use--generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.
Atsiliepimai